New in CME courses -CDK 4/6 Inhibition in Breast Cancer: Self Study Modules I & II

Topic: Oncology

Target Audience: Oncology nurses, nurse navigators, nurse practitioners, physician assistants, medical technicians, and other healthcare professionals involved in the care and management of patients with advanced or metastatic breast cancer.

These self study modules contain case examples designed to help learners:

Find out how to discuss the risks and benefits of CDK 4/6 inhibitors for the treatment of estrogen receptor–positive, HER2-negative advanced breast cancer with patients and their families

Understand how to describe education/shared decision-making strategies to help patients understand their treatment options in estrogen receptor–positive, HER2-negative advanced breast cancer

Learn how to evaluate proper dosing administration, monitoring, and adherence strategies of CDK 4/6 inhibitors for the treatment of estrogen receptor–positive, HER2-negative advanced breast cancer

Learn the role of a nurse navigator in the management of patients with advanced or metastatic breast cancer being treated with CDK 4/6 inhibitors

Each Self Study Module offers 1 AMA PRA Category 1 Credit™, or 1 ANCC contact hour. Click on the title below to proceed to the course!

CDK 4/6 Inhibition in Breast Cancer: Self-Study Module I 

CDK 4/6 Inhibition in Breast Cancer: Self-Study Module II